The Wall Street Transcript4h
Interview with the CEO: MediWound Ltd. (NASDAQ:MDWD)
Please give me an overview of the company and its services. Mr. Gonen: MediWound is a global leader in next generation enzymatic therapeutics for tissue repair. Our core active pharmaceutical ...
The Wall Street Transcript4h
New Drug Trials Spur Continued Interest in Anti-Obesity Space
The big news is that the Fed cut rates by 50 basis points yesterday, and the market is dramatically rising. How is your coverage space looking? Dr. Phipps: Well, admittedly, the XBI, which is the ETF ...
The Wall Street Transcript4h
Interview with the President and CEO: CompuMed Inc. (OTCMKTS:CMPD)
Could you tell me about the company? Mr. Keddie: CompuMed is kind of a unique space. We’re in the telemedicine space. We started out, actually, in the early days, building echocardiogram devices, and ...
The Wall Street Transcript4h
Skip the Needles — Delivering Biologics in Oral Form
We spoke about two years ago. How would you compare today’s market to back then? Mr. Vandermosten: Two years ago would have been fall 2022, and I think we had seen about a year of pullback in the life ...
The Wall Street Transcript4h
Interview with the CEO and Managing Director: Mesoblast Limited (NASDAQ:MESO)
It’s been a few years since you spoke with The Wall Street Transcript. So, let’s start with a brief overview and history of the company. Dr. Itescu: Sure. So, we’re a mature company. We’re listed on ...
The Wall Street Transcript5h
Interview with the CEO: Neuren Pharmaceuticals Ltd. (OTCMKTS:NURPF)
So let’s start with a brief history of the company and its mission. Mr. Pilcher: Sure. So Neuren is an interesting company, which has had a long history and a couple of incarnations. Twenty years ago ...
The Wall Street Transcript5h
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
First please introduce your firm and your coverage. You recently said that this is a very problematic market. Why so? What prompts the change in your outlook? Dr. Brozak: I am President of WBB ...
The Wall Street Transcript5h
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Please provide an overview of your coverage and the subsectors, cap sizes, and primary names that you follow. Mr. Beatty: I cover biotech. And within biotech, most of my coverage is within the ...
The Wall Street Transcript5h
Interview with the President and CEO: Premier Inc. (NASDAQ:PINC)
Could you tell me about Premier? Mr. Alkire: Sure. Premier is a health care improvement company. We have two different segments to our business. We have a supply chain segment and a performance ...
The Wall Street Transcript10d
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Mason D. King, CFA, is a Principal, Vice President, Director of Public Equity Investment Strategies, and Portfolio Manager at Luther King Capital Management. He joined the firm in 2004. Earlier ...
The Wall Street Transcript10d
Kodiak Gas Services Inc.
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings October 10, 2024 King, Mason D.